Events Calendar

Mon
Tue
Wed
Thu
Fri
Sat
Sun
M
T
W
T
F
S
S
26
27
28
29
30
31
1
2
4
5
6
7
8
10
11
12
12:00 AM - PFF Summit 2015
13
14
15
17
18
19
20
21
22
23
24
25
26
27
28
29
30
1
2
3
4
5
6
NextEdge Health Experience Summit
2015-11-03 - 2015-11-04    
All Day
With a remarkable array of speakers and panelists, the Next Edge: Health Experience Summit is shaping-up to be an event that attracts healthcare professionals who [...]
mHealthSummit 2015
2015-11-08 - 2015-11-11    
All Day
Anytime, Anywhere: Engaging Patients and ProvidersThe 7th annual mHealth Summit, which is now part of the HIMSS Connected Health Conference, puts new emphasis on innovation [...]
24th Annual Healthcare Conference
2015-11-09 - 2015-11-11    
All Day
The Credit Suisse Healthcare team is delighted to invite you to the 2015 Healthcare Conference that takes place November 9th-11th in Arizona. We have over [...]
PFF Summit 2015
2015-11-12 - 2015-11-14    
All Day
PFF Summit 2015 will be held at the JW Marriott in Washington, DC. Presented by Pulmonary Fibrosis Foundation Visit the www.pffsummit.org website often for all [...]
2nd International Conference on Gynecology & Obstetrics
2015-11-16 - 2015-11-18    
All Day
Welcome Message OMICS Group is esteemed to invite you to join the 2nd International conference on Gynecology and Obstetrics which will be held from November [...]
Events on 2015-11-03
NextEdge Health Experience Summit
3 Nov 15
Philadelphia
Events on 2015-11-08
mHealthSummit 2015
8 Nov 15
National Harbor
Events on 2015-11-09
Events on 2015-11-12
PFF Summit 2015
12 Nov 15
Washington, DC
Events on 2015-11-16
Latest News

Factors Predicting Poor Locoregional Control in Tongue Cancer

In patients with pT1-2N0 oral tongue squamous cell carcinoma undergoing partial glossectomy and elective neck dissection, inferior locoregional control (LRC) was associated with depth of invasion, lymphovascular space invasion, and positive glossectomy specimen margins. These retrospective findings, presented at the 2024 ASTRO Multidisciplinary Head and Neck Cancers Symposium, remained significant even in cases with final negative tumor bed margins.At a median follow-up of 45.6 months, the all-comer patient population exhibited 3-year locoregional control (LRC) and overall survival (OS) rates of 88.0% and 92.5%, respectively. Among patients with pT1 disease, these rates were 92.0% and 95.2%, while in those with pT2 disease, the rates were 85.0% and 90.5%.

However, during the multivariate analysis, individuals with positive glossectomy margins exhibited poorer locoregional control (HR, 6.66; 95% CI, 1.60-27.78; P = .009). Lymphovascular space invasion (HR, 6.90; 95% CI, 1.42-33.65; P = .02) and depth of invasion (HR, 1.31; 95% CI, 1.06-1.63; P = .01) were also correlated with diminished locoregional control.

The lead study author, Michael Modzelewski, MD, along with the co-investigators, stated in a poster presented at the meeting, “Patients with these risk factors may be considered for adjuvant radiotherapy to optimize disease control.”

Individuals with early-stage tongue squamous cell carcinoma typically do not undergo adjuvant radiation due to their low recurrence risk. After surgery, the status of the primary glossectomy specimen margin has been observed to have a stronger correlation with local recurrence than the status of additional tumor bed margins, as stated by the authors.

The investigators aimed to identify the pathological factors associated with locoregional recurrence in patients with early-stage tongue squamous cell carcinoma who underwent surgery alone. Additionally, they explored the impact of a positive glossectomy specimen margin on disease control concerning final negative tumor bed margins.

The research included 110 patients diagnosed with pT1-2N0 oral tongue squamous cancer, adhering to the American Joint Committee on Cancer (AJCC) 8th edition criteria. These individuals underwent partial glossectomy and elective dissection from 2015 to 2021, excluding adjuvant radiation. Pathology reports were examined for factors such as tumor size, depth of invasion, glossectomy specimen margin, final tumor bed margin status, and perineural or lymphovascular space invasion. Individuals with positive final margins or a history of head and neck radiation were excluded.

The Kaplan-Meier method was employed to estimate locoregional control (LRC) and overall survival (OS), with a Cox proportional hazards model identifying prognostic factors for LRC in multivariate analysis.

Concerning baseline characteristics, the median age was 52 years, with the majority being male (54.5%) and having pT2 stage disease (58.2%). There were 33 lymph nodes dissected on average, and the median tumor size measured 16 mm, with a depth of invasion reaching 5 mm.

The majority of patients did not exhibit perineural invasion (84.7%), while 3.6% had lymphovascular space invasion. Positive glossectomy specimen margins were observed in 8.2% of cases.

Further findings revealed that among patients with positive glossectomy specimen margins and those without, the 3-year locoregional control (LRC) rates were 66.7% and 89.5%, respectively. Similarly, the rates were 0.0% for individuals with lymphovascular space invasion and 89.4% for those without. Among the 8 patients experiencing regional failure, 5 had recurrence in the ipsilateral neck alone (62.5%), 2 in the bilateral neck (25.0%), and 1 with isolated contralateral neck recurrence (12.5%).